Santini D - Search Results

1

Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary.

Fusco V, Santini D, Campisi G, Bertoldo F, Lanzetta G, Ibrahim T, Bertetto O, Numico G, Addeo A, Berruti A, Bettini G, Saia G, Bedogni A. Fusco V, et al. Among authors: santini d. JCO Oncol Pract. 2020 Mar;16(3):142-145. doi: 10.1200/JOP.19.00645. Epub 2020 Jan 24. JCO Oncol Pract. 2020. PMID: 32048935 No abstract available.

2

Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle.

Bertoldo F, Santini D, Lo Cascio V. Bertoldo F, et al. Among authors: santini d. Nat Clin Pract Oncol. 2007 Dec;4(12):711-21. doi: 10.1038/ncponc1000. Nat Clin Pract Oncol. 2007. PMID: 18037875 Review.

3

Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancer.

Bertoldo F, Tonini G, Vincenzi B, Santini D. Bertoldo F, et al. Among authors: santini d. Nat Rev Clin Oncol. 2009 Apr;6(4):191-2. doi: 10.1038/nrclinonc.2009.24. Nat Rev Clin Oncol. 2009. PMID: 19333223 Review. No abstract available.

4

Can we consider zoledronic acid a new antitumor agent? Recent evidence in clinical setting.

Santini D, Virzi V, Fratto ME, Bertoldo F, Sabbatini R, Berardi R, Calipari N, Ottaviani D, Ibrahim T. Santini D, et al. Curr Cancer Drug Targets. 2010 Feb;10(1):46-54. doi: 10.2174/156800910790980223. Curr Cancer Drug Targets. 2010. PMID: 20088792 Review.

5

The dark side of the moon: the PI3K/PTEN/AKT pathway in colorectal carcinoma.

Silvestris N, Tommasi S, Petriella D, Santini D, Fistola E, Russo A, Numico G, Tonini G, Maiello E, Colucci G. Silvestris N, et al. Among authors: santini d. Oncology. 2009;77 Suppl 1:69-74. doi: 10.1159/000258498. Epub 2010 Feb 2. Oncology. 2009. PMID: 20130434 Review.

6

Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients.

Santini D, Vincenzi B, Adamo V, Addeo R, Fusco V, Russo A, Montemurro F, Roato I, Redana S, Lanzetta G, Satolli MA, Berruti A, Leoni V, Galluzzo S, Antimi M, Ferraro G, Rossi M, Del Prete S, Valerio MR, Marra M, Caraglia M, Tonini G. Santini D, et al. Oncol Rep. 2011 Jun;25(6):1545-8. doi: 10.3892/or.2011.1235. Epub 2011 Mar 28. Oncol Rep. 2011. PMID: 21455582 Free article.

7

New targets, new drugs for metastatic bone pain: a new philosophy.

Pantano F, Zoccoli A, Iuliani M, Lanzetta G, Vincenzi B, Tonini G, Santini D. Pantano F, et al. Among authors: santini d. Expert Opin Emerg Drugs. 2011 Sep;16(3):403-5. doi: 10.1517/14728214.2011.588600. Epub 2011 May 31. Expert Opin Emerg Drugs. 2011. PMID: 21623686

8

The role of bone microenvironment, vitamin D and calcium.

Santini D, Pantano F, Vincenzi B, Tonini G, Bertoldo F. Santini D, et al. Recent Results Cancer Res. 2012;192:33-64. doi: 10.1007/978-3-642-21892-7_2. Recent Results Cancer Res. 2012. PMID: 22307369 Review.

9

Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study.

Rozzi A, Santini D, Salerno M, Bordin F, Mancuso A, Minniti G, Nardoni C, Corona M, Falbo PT, Recine F, Lanzetta G. Rozzi A, et al. Among authors: santini d. Med Oncol. 2013 Mar;30(1):407. doi: 10.1007/s12032-012-0407-5. Epub 2013 Jan 10. Med Oncol. 2013. PMID: 23307245 Clinical Trial.

10

'Old' and 'new' drugs for the treatment of cancer pain.

Santini D, Lanzetta G, Dell'Aquila E, Vincenzi B, Venditti O, Russano M, Papapietro N, Denaro V, Tonini G, Ripamonti C. Santini D, et al. Expert Opin Pharmacother. 2013 Mar;14(4):425-33. doi: 10.1517/14656566.2013.774375. Expert Opin Pharmacother. 2013. PMID: 23438421 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,087 results

Search Page